Anxiety studies

Effectiveness of parenting training program to improve the mental health of mothers and the well-being of their children in Anxiety

This study isn't currently recruiting.

Countries

Bangladesh

Sponsor

Save the Children

Testing the mHealth app SyD to improve the physical and mental wellbeing of UK healthcare workers

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Southern Health NHS Foundation Trust

The effects of the use of virtual reality (VR) during dental treatment

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Plymouth University Peninsula Schools of Medicine and Dentistry (UK)

The efficacy of nutraceuticals in the treatment of chronic insomnia

This study isn't currently recruiting.

Countries

Italy

Sponsor

Sapienza University of Rome

Virtual reality intervention for anxiety in children with ASD

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Northumberland, Tyne and Wear NHS Foundation Trust

Virtual reality minimizes anxiety in children and adolescents with life-limiting conditions: a controlled study

This study isn't currently recruiting.

Countries

Czechia

Sponsor

Vlček Family Foundation

Visual distraction to reduce anxiety and pain during nerve block injection

This study isn't currently recruiting.

Countries

Netherlands

Sponsor

Spaarne Gasthuis

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, 10-WEEK PLACEBO CONTROLLED FIXED DOSE STUDY OF PD 0332334 AND PAROXETINE EVALUATING THE EFFICACY AND SAFETY OF PD 0332334 FOR THE TREATMENT OF G...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Hungary

Sponsor

Pfizer Inc., 235 East 42nd Street, New York, NY 10017

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, 10-WEEK, PLACEBO CONTROLLED FIXED DOSE STUDY OF PD 0332334 AND PAROXETINE EVALUATING THE EFFICACY AND SAFETY OF PD 0332334 FOR THE TREATMENT ...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany, Hungary, Italy

Sponsor

PFIZER

An 8-week, double blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy and safety of 2 fixed doses of SR58611A (175 mg q12 and 350 m...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Czechia

Sponsor

sanofi-aventis recherche & développement

An eight-week, double-blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy, safety and tolerability of a fixed dose of SR58611A (350...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria, Estonia, Sweden

Sponsor

Sanofi-Synthelabo Recherche

Duloxetina versus placebo en el tratamiento de pacientes de avanzada edad con trastorno de ansiedad generalizada Duloxetine versus Placebo in the Treatment of Elderly Patients with Generalized Anx...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom, Austria, Germany, + 1 other

Sponsor

LILLY S.A.